(NewsUSA) - You can't see them. You can't feel them. You can't fight them once they attack. But they're there -- "natural-born killers" in their tens of trillions. A deadly strike-force of antibiotic-resistant 'supergerms' lurking in the shadows of America's over-burdened, under-resourced hospital system. An army of lethal microbes, silently waiting to infect all who come into contact with them.
Just how serious is the superbug threat? Superbugs, aka hospital-acquired infections (HAIs), now affect one in 20 patients in the U.S., killing more than 100,000 people each year -- that's more than AIDS, breast cancer and car accidents combined. Ominously, more than two-thirds of these infections occur after a patient has been admitted.
Ironically, HAIs can be prevented if strict disinfection guidelines are adhered to by doctors and hospital staff. Yet, the lack of mass compliance to date suggests that one day soon we could see lawsuits pale the recent asbestos crisis into insignificance.
Infections contracted during hospital stays are the fourth largest killer in America. They add an estimated $33 billion to hospital and health care costs each year -- a crushing financial burden largely absorbed by overwhelmed hospitals.
The need for greater post-admittance infection prevention is, according to many industry pundits, rapidly approaching crisis point. It's also posing some challenging questions: What if there were a sudden, massive escalation of the avian (bird) flu, or a contagion-like plague, or a large-scale bioterrorist attack? Do we have the infrastructure and mechanisms to cope? Or could any one of the above threaten to sink America's hospital system "to its knees?"
The solution to their eradication may already be here.
Largely unknown to the outside world, a team of scientists and bio-medical researchers working out of labs in Innovation Park, Queen's University in Kingston, Ontario, have spent the past three years developing and perfecting what could become the world's most effective weapon in the war against HAIs.
This patented, new-generation "sterilization and disinfection" technology, AsepticSure, is the brain child of bio-tech company, Medizone International, Inc. Already the recipient of a World Health Organization-sponsored award for innovation and peer-reviewed by the prestigious American Journal of Infection Control, AsepticSure -- an ozone vapor-based fumigant -- has demonstrated unprecedented 100 percent kill rates against the world's deadliest superbug strains. These include MRSA, VRE, C.difficile, E.coli, Pseudomonas and more.
"While there's no denying that HAIs continue to flourish in hospitals and health care organizations across every state of America and throughout the world at this time, AsepticSure looks set to inflict the first real blow to a pandemic-in-the-making that, for decades, has largely gone unchecked," says Bruce Smeaton, Medizone spokesperson.